Ionis Pharmaceuticals (IONS) to Present Phase 2 Results of donidalorsen

Go back to Ionis Pharmaceuticals (IONS) to Present Phase 2 Results of donidalorsen
(NASDAQ: IONS) Delayed: 56.71 -1.38 (2.38%)
Previous Close $58.09    52 Week High $62.68 
Open $52.15    52 Week Low $19.59 
Day High $57.43    P/E N/A 
Day Low $52.15    EPS $0.00 
Volume 9,097,736